Prostate Cancer, Version 3.2024

M. Schaeffer, Edward; Srinivas, Sandy; Adra, Nabil; An, Yi; L. Bitting, Rhonda; F. Chapin, Brian; H. Cheng, Heather; V. D’Amico, Anthony; Desai, Neil; B. Dorff, Tanya; A. Eastham, James; A. Farrington, Thomas; Gào, Xīn; Gupta, Shilpa; Guzzo, Thomas; E. Ippolito, Joseph; Jeffrey Karnes, R.; Kuettel, Michael; M. Lang, Joshua; L. Lotan, Tamara; R. McKay, Rana; M. Morgan, Todd; M. Pow‐Sang, Julio; E. Reiter, Robert; Roach, Mack; P. Robin, Tyler; Rosenfeld, Stan; Shabsigh, Ahmad; E. Spratt, Daniel; Z. Szmulewitz, Russell; A. Teply, Benjamin; D. Tward, Jonathan; K. Valicenti, Richard; Wong, J.K.; Snedeker, Jenna; A. Freedman-Cass, Deborah

doi:10.6004/jnccn.2024.0019

Public

Prostate Cancer, Version 3.2024

Published in Journal of the National Comprehensive Cancer Network • Apr 1, 2024

Authors:

Edward M. Schaeffer

Sandy Srinivas

Nabil Adra

Abstract

The NCCN Guidelines for Prostate Cancer include recommendations for staging and risk assessment after a prostate cancer diagnosis and for the care of patients with localized, regional, recurrent, and metastatic disease. These NCCN Guidelines Insights summarize the panel's discussions for the 2024 up...

Subject

Medicine

Prostate cancer

Risk stratification

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!